Appointment(s)
Editorial Board Member, The Scientific World Journal
Editorial Board Member, World Journal of Clinical Oncology
Editorial Board Member, BioScience Trends
Editorial Board Member, The Open Pathology Journal
Editorial Board Member, Glycobiology Insights
Editorial Board Member, Bone and Tissue Regeneration Insights
Editorial Board Member, Journal of Medical & Biological Sciences\
Editorial Board Member, Annals of Microscopy
Coordinator, Honours Project in Life Sciences (LSM4199)
Coordinator, Undergraduate Research Opportunities Programme in Science (UROPS)
Research Areas/Research Interest
Roles of glycosaminoglycans and proteoglycans in breast, prostate, gastric and other cancers
Wound healing
2021) Prognostic significance of phosphoglycerate dehydrogenase in breast cancer. Breast Cancer Res Treat 186:655-665.
Chandrika M, Chua PJ, Muniasamy U, Huang RY, Thike AA, Ng CT, Tan PH, Yip GW, Bay BH
(2023) C1QBP mediates breast cancer cell proliferation and growth via multiple potential signalling pathways. Int J Mol Sci 24:1343.
Scully OJ, Shyamasundar S, Matsumoto K, Dheen ST, Yip GW, Bay BH
(2023) Cancer stem cells as attractive targets for breast cancer therapy. Front Oncol 13:1151742.
Ibrahim SA, Yip GW, Götte M
(2022) Theranostic applications of glycosaminoglycans in metastatic renal cell carcinoma. Cancers (Basel) 15:266.
Hua SH, Viera M, Yip GW, Bay BH
(2022) The natural antisense transcript HAS2-AS1 regulates breast cancer cells aggressiveness independently from hyaluronan metabolism. Matrix Biol 109:140-161.
Parnigoni A, Caon I, Teo WX, Hua SH, Moretto P, Bartolini B, Viola M, Karousou E, Yip GW, Götte M, Heldin P, Passi A, Vigetti D
(2022) KIF21A regulates breast cancer aggressiveness and is prognostic of patient survival and tumor recurrence. Breast Cancer Res Treat 191:63-75.
Lucanus AJ, Thike AA, Tan XF, Lee KW, Guo S, King VPC, Yap VB, Bay BH, Tan PH, Yip GW
(2021) Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers. Cell Death Discov 7:265.
Loo SY, Syn NL, Koh AP, Teng JC, Deivasigamani A, Tan TZ, Thike AA, Vali S, Kapoor S, Wang X, Wang JW, Tan PH, Yip GW, Sethi G, Huang RY, Hui KM, Wang L, Goh BC, Kumar AP
(2021) Targeting CD82/KAI1 for precision therapeutics in surmounting metastatic potential in breast cancer. Cancers (Basel) 13:4486.
Viera M, Yip GWC, Shen HM, Baeg GH, Bay BH
(2021) Novel therapeutics in breast cancer. Curr Med Chem 28:5032-5033.
Yip GW, Bay BH
(2021) Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing. Mod Pathol 34:1320-1332.
Ng CCY, Md Nasir ND, Loke BN, Tay TKY, Thike AA, Rajasegaran V, Liu W, Lee JY, Guan P, Lim AH, Chang KTE, Gudi MA, Madhukumar P, Tan BKT, Tan VKM, Wong CY, Yong WS, Ho GH, Ong KW; International Fibroepithelial Consortium; Yip GWC, Bay BH, Tan P, Teh BT, Tan PH
(2021) The heparan sulfate proteoglycan syndecan-1 regulates colon cancer stem cell function via a focal adhesion kinase-Wnt signaling axis. FEBS J 288:486-506.
Kumar Katakam S, Tria V, Sim WC, Yip GW, Molgora S, Karnvas T, Elghonaimy EA, Pelucchi P, Piscitelli E, Ibrahim SA, Zucchi I, Reinbold R, Greve B, Götte M
(2020) Diagnostic value of serum HER2 levels in breast cancer: a systematic review and meta-analysis. BMC Cancer 20:1049.
Shamshirian A, Aref AR, Yip GW, Ebrahimi Warkiani M, Heydari K, Razavi Bazaz S, Hamzehgardeshi Z, Shamshirian D, Moosazadeh M, Alizadeh-Navaei R
(2020) Parathyroid allotransplantation to treat post-thyroidectomy hypoparathyroidism: A review of case studies. Surgeon 19:183-192.
Parameswaran R, Samuel M, Satish RL, Kripesh A, Moorthy V, Vajjhala R, Ng XL, Yip GW, Voon FC, Chandran M
(2020) The role of hydroxychloroquine in COVID-19: a systematic review and meta-analysis. Ann Acad Med Singap 49:789-800.
Shamshirian A, Hessami A, Heydari K, Navaei RA, Ebrahimzadeh MA, Yip GW, Ghasemian R, Sedaghat M, Baradaran H, Yazdi SM, Aboufazeli E, Jafarpour H, Dadgostar E, Tirandazi B, Sadeghnezhad R, Karimifar K, Eftekhari A, Shamshirian D
(2019) In vitro evaluation of candidate gene targets for cancer therapy. Methods Mol Biol 1974:21-30.
Tan XF, Teo WX, Yip GW
